149 related articles for article (PubMed ID: 18163513)
1. Prevalence of malignancy in psoriatic arthritis.
Rohekar S; Tom BD; Hassa A; Schentag CT; Farewell VT; Gladman DD
Arthritis Rheum; 2008 Jan; 58(1):82-7. PubMed ID: 18163513
[TBL] [Abstract][Full Text] [Related]
2. Malignancy in psoriatic disease: Results from prospective longitudinal cohorts.
Polachek A; Muntyanu A; Lee KA; Ye JY; Chandran V; Cook RJ; Gladman DD
Semin Arthritis Rheum; 2021 Feb; 51(1):144-149. PubMed ID: 33383290
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort.
Gross RL; Schwartzman-Morris JS; Krathen M; Reed G; Chang H; Saunders KC; Fisher MC; Greenberg JD; Putterman C; Mease PJ; Gottlieb AB; Kremer JM; Broder A
Arthritis Rheumatol; 2014 Jun; 66(6):1472-81. PubMed ID: 24591475
[TBL] [Abstract][Full Text] [Related]
4. Malignancy incidence in patients with psoriatic arthritis: a comparison cohort-based incidence study.
Wilton KM; Crowson CS; Matteson EL
Clin Rheumatol; 2016 Oct; 35(10):2603-7. PubMed ID: 27572325
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, incidence, and risk factors of malignancy in patients with rheumatoid arthritis: a nationwide cohort study from Korea.
Ko KM; Moon SJ
Korean J Intern Med; 2023 Jan; 38(1):113-124. PubMed ID: 34407599
[TBL] [Abstract][Full Text] [Related]
6. Rates of Cancers and Opportunistic Infections in Patients With Psoriatic Arthritis Compared With Patients Without Psoriatic Arthritis.
Hagberg KW; Li L; Peng M; Paris M; Shah K; Jick SS
J Clin Rheumatol; 2016 Aug; 22(5):241-7. PubMed ID: 26886439
[TBL] [Abstract][Full Text] [Related]
7. Mortality in psoriatic arthritis: Risk, causes of death, predictors for death.
Elalouf O; Muntyanu A; Polachek A; Pereira D; Ye JY; Lee KA; Chandran V; Cook RJ; Gladman DD
Semin Arthritis Rheum; 2020 Aug; 50(4):571-575. PubMed ID: 32454305
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LT; Kristensen LE; Feltelius N; Hetland ML; Askling J;
Ann Rheum Dis; 2017 Jan; 76(1):105-111. PubMed ID: 27147709
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Malignancies in a Cohort of Psoriatic Arthritis Patients Taking Traditional Disease Modifying Antirheumatic Drug and Tumor Necrosis Factor Inhibitor Therapy: An Observational Study.
Costa L; Caso F; Del Puente A; Di Minno MN; Peluso R; Scarpa R
J Rheumatol; 2016 Dec; 43(12):2149-2154. PubMed ID: 27633825
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
11. The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study.
Eder L; Haddad A; Rosen CF; Lee KA; Chandran V; Cook R; Gladman DD
Arthritis Rheumatol; 2016 Apr; 68(4):915-23. PubMed ID: 26555117
[TBL] [Abstract][Full Text] [Related]
12. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
13. Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register.
Fagerli KM; Kearsley-Fleet L; Mercer LK; Watson K; Packham J; Symmons DPM; Hyrich KL
Rheumatology (Oxford); 2019 Jan; 58(1):80-85. PubMed ID: 30137485
[TBL] [Abstract][Full Text] [Related]
14. Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis.
Hashimoto A; Arinuma Y; Nagai T; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
Intern Med; 2012; 51(13):1683-8. PubMed ID: 22790126
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
Husted JA; Thavaneswaran A; Chandran V; Eder L; Rosen CF; Cook RJ; Gladman DD
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1729-35. PubMed ID: 21905258
[TBL] [Abstract][Full Text] [Related]
16. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824
[TBL] [Abstract][Full Text] [Related]
17. Improved survival in psoriatic arthritis with calendar time.
Ali Y; Tom BD; Schentag CT; Farewell VT; Gladman DD
Arthritis Rheum; 2007 Aug; 56(8):2708-14. PubMed ID: 17665458
[TBL] [Abstract][Full Text] [Related]
18. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.
Rahmattulla C; Berden AE; Wakker SC; Reinders ME; Hagen EC; Wolterbeek R; Bruijn JA; Bajema IM
Arthritis Rheumatol; 2015 Dec; 67(12):3270-8. PubMed ID: 26246307
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
